ellura Cranberry Extract 36 mg PACs Capsules 30ct — Clinically Backed Urinary Tract Support, Vegan

ellura delivers 36 mg of soluble, bioactive A‑type proanthocyanidins (PACs) per capsule—clinically studied cranberry extract formulated for daily urinary tract support.

ellura by Pharmatoka is a concentrated cranberry fruit juice extract standardized to provide the specific 36 mg dose of soluble A‑type PACs used in clinical research. Each easy once‑daily capsule is derived from whole cranberry fruit juice concentrate (not skins, seeds, or pulp) and measured with the validated DMAC/A2 method to confirm the bioactive PAC content. The formula is vegan, gluten‑free, non‑GMO, and free from added sugars, sweeteners, and dyes.

How quickly will ellura start to work?

ellura is designed for fast absorption and once‑daily convenience. Some users report measurable effects within hours, while the pattern and consistency of results can vary by individual. For many, a single capsule a day maintains the clinically studied PAC level used in trials.

• One capsule per day — simple dosing.
• Formulated from cranberry fruit juice concentrate for consistent PAC delivery.
• Measured using DMAC/A2, the scientific assay used in clinical studies.

What makes this cranberry extract different from other cranberry supplements?

Unlike products made from cranberry skins, seeds, or pulp, ellura is manufactured from 100% concentrated cranberry fruit juice extract, which preserves the soluble, bioactive A‑type PACs that were studied clinically. The production process and PAC quantification are controlled from field to capsule to ensure each dose contains the targeted 36 mg.

• Proprietary Gikacran extract sourced from whole fruit juice concentrate.
• Standardized PAC amount (36 mg) matching clinical research.
• Full production oversight by Pharmatoka to maintain consistency and purity.

Is ellura safe to take with dietary restrictions?

ellura is formulated to be compatible with common dietary preferences and sensitivities: it is vegan, gluten‑free, and non‑GMO, with no added sugars, sweeteners, or artificial dyes. As with any supplement, consult a healthcare professional if you are pregnant, nursing, taking medications, or have chronic health conditions.

• Suitable for vegan and gluten‑sensitive diets.
• No added sugars, sweeteners, or dyes included.
• Manufactured with quality controls to ensure ingredient integrity.

How is product quality verified?

ellura’s PAC content is quantified using the scientifically validated DMAC/A2 assay—the same method employed in the clinical studies that identified the 36 mg dose. Pharmatoka oversees cultivation, extraction, and manufacturing processes to keep traceability and consistency intact from harvest through encapsulation.

• DMAC/A2 assay confirms soluble A‑type PAC levels.
• Field‑to‑capsule oversight by Pharmatoka ensures batch consistency.
• Recommended by healthcare professionals for over 20 years.

Who is this for: ellura is appropriate for adults seeking a clinically characterized cranberry extract standardized to the 36 mg soluble A‑type PAC dose used in research. It appeals to people who prefer a single once‑daily capsule, those avoiding animal ingredients or gluten, and anyone who values traceable production and laboratory‑verified active components. If you have specific health concerns or take prescription medicines, check with your healthcare provider before beginning any new supplement.

Ingredients

Each capsule of ellura delivers 36 mg of soluble, bioactive A-type PACs (proanthocyanidins) from 206 mg of concentrated cranberry fruit juice extract (Gikacran), the clinically backed ingredient that may help reduce the ability of certain bacteria to adhere to bladder wall, supporting urinary tract health.* Encapsulated in a 100% plant-based formula, ellura is designed to support optimal bioactivity and consistency. Inactive ingredients: Mannitol, magnesium stearate, silicon dioxide, and the vegetable capsule shell (hydroxypropyl methylcellulose) are common natural plant-based excipients used to ensure product stability and the bioavailability of PACs.